Srivastava, S., Sherman, C., Meek, C., Leff, R., & Gumbo, T. (2011). Pharmacokinetic Mismatch Does Not Lead to Emergence of Isoniazid- or Rifampin-Resistant Mycobacterium tuberculosis but to Better Antimicrobial Effect: A New Paradigm for Antituberculosis Drug Scheduling. American Society for Microbiology.

Srivastava, Shashikant, Carleton Sherman, Claudia Meek, Richard Leff, and Tawanda Gumbo. Pharmacokinetic Mismatch Does Not Lead to Emergence of Isoniazid- or Rifampin-Resistant Mycobacterium Tuberculosis but to Better Antimicrobial Effect: A New Paradigm for Antituberculosis Drug Scheduling. American Society for Microbiology, 2011.

Srivastava, Shashikant, et al. Pharmacokinetic Mismatch Does Not Lead to Emergence of Isoniazid- or Rifampin-Resistant Mycobacterium Tuberculosis but to Better Antimicrobial Effect: A New Paradigm for Antituberculosis Drug Scheduling. American Society for Microbiology, 2011.